↓ Skip to main content

CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex

Overview of attention for article published in Leukemia, January 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
8 news outlets
twitter
20 X users

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
58 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex
Published in
Leukemia, January 2019
DOI 10.1038/s41375-019-0382-3
Pubmed ID
Authors

Luisa Schmidt, Elizabeth Heyes, Lisa Scheiblecker, Thomas Eder, Giacomo Volpe, Jon Frampton, Claus Nerlov, Peter Valent, Jolanta Grembecka, Florian Grebien

X Demographics

X Demographics

The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 58 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 21%
Student > Bachelor 9 16%
Researcher 6 10%
Student > Master 5 9%
Student > Postgraduate 3 5%
Other 4 7%
Unknown 19 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 18 31%
Agricultural and Biological Sciences 6 10%
Medicine and Dentistry 6 10%
Immunology and Microbiology 3 5%
Nursing and Health Professions 2 3%
Other 3 5%
Unknown 20 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 69. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 July 2019.
All research outputs
#568,082
of 24,003,070 outputs
Outputs from Leukemia
#83
of 5,213 outputs
Outputs of similar age
#13,974
of 444,292 outputs
Outputs of similar age from Leukemia
#4
of 104 outputs
Altmetric has tracked 24,003,070 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,213 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,292 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 104 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.